Introduction
Keratins, the largest subgroup of intermediate filament proteins are subdivided into Type I acidic and Type II basic, based on their molecular weight and biochemical properties [1, 2] . Epithelial tissues express different pairs of keratins in tissue specific and differentiation state specific manner, e.g., simple epithelia express K8/ 18, K7/19, and K20, whereas stratified epithelia express K1/10, K5/K14, K6/17, etc. [3, 4] . Keratins share a common prototype structure of all cytoplasmic intermediate filament proteins. All keratin filaments have a highly conserved central coiled-coil a-helical 'rod' domain flanked by a non-a-helical N-terminal 'head' and C-terminal 'tail' domains of various lengths [5, 6] . The head and tail domains are known to harbor specific sites for various post-translational modifications like phosphorylation, glycosylation, ubiquitination, and sumoylation [7, 8] . Being cytoskeletal proteins, the widely accepted function of keratins was to only provide mechanical stability and integrity to the epithelial tissue and protect them from various cellular stresses by forming structural scaffolds [9] [10] [11] . Recent reports confirmed that aside from their cytoprotective functions, they also perform some important regulatory functions by modulating certain signaling pathways [12, 13] . Most of these functions include, modulation of protein localization, targeting, trafficking, and synthesis [3, 14, 15] , protecting cells from apoptotic stress [16] , cell motility [17] , apico-basal polarity [18] , modulation of the cell adhesion, size, cell-cycle progression [14, [19] [20] [21] , etc. The simple epithelia express K8/18 as their predominant keratin pair and most of the abovementioned functions are attributed to this pair. This keratin pair, is often aberrantly expressed in squamous cell carcinomas where its expression is correlated with increased invasion and poor prognosis. Aside from being used as a diagnostic tumor marker, K8/18 is also reported to modulate different signaling pathways involved in tumor progression [20, [22] [23] [24] . Previous report from our laboratory has shown that forced expression of K8/18 leads to increased invasiveness and tumorigenic potential of FBM cell line [25] . Furthermore, we have shown that depletion of keratin 8/18 in an oral squamous carcinoma-derived AW13516 cell line leads to decreased tumorigenic potential by deregulating a6b4 integrin pathway together with the changes in fascin-mediated actin organization [26, 27] . These results suggest that aberrant expression of K8/18 could contribute to neoplastic progression of oral SCC. Squamous cell carcinoma (SCC), or epidermoid carcinoma, represent about 20% of skin malignancies which are curable at early stages, but delayed diagnosis leads to metastasis [28, 29] . Like other SCCs, skin SCC tissues have also been reported to aberrantly express K8/18. In addition, an in vivo study by Casanova et al. [30] showed that transgenic mice expressing human K8 in the epidermis have a dramatic increase in the progression of papillomas toward malignancy. Despite current extended knowledge regarding the molecular genetics of skin SCC, still little is known about the involvement of K8 in neoplastic progression of the same. Hence, further studies are required to elucidate the role, if any, of K8 in neoplastic progression of skin squamous cell carcinomas and mechanism underlying the same.
In the present study, depletion of K8 in skin epidermoid carcinoma-derived A431 cells resulted in its decreased tumorigenic potential. Furthermore, we performed TMT-based quantitative proteomics analysis so as to sum up the broad-spectrum effect of K8 depletion on tumorigenic potential of skin SCCderived A431 cells and the mechanism involved. Our quantitative proteomics data and subsequent IPA analysis revealed many biological pathways involved in cancer progression to be altered. In association with this, we could identify two major pathways; TMS1-NF-jB-mediated K17 degradation and MARCKSL1-Paxillin-mediated Rac activity modulation to regulate apoptotic sensitivity and migratory potential of these cells, respectively. Altogether our phenotypic and molecular data provide a comprehensive information about multiple signaling pathways being altered upon K8 depletion in a single frame, further signifying its role in neoplastic progression of skin SCC.
Results

Generation of Keratin 8 knockdown stable clones
K8 knockdown (K8-KD1/K8-KD2) and vector control stable clones were generated by transfecting shRNA-K8.2 (the shRNA construct made earlier in the laboratory [26] ) or the empty vector (pTU6-PURO) into the skin SCC-derived A431 cells. Immunoblotting along with semiquantitative and real-time PCR analysis showed a substantial reduction (~80%) in K8 protein as well as mRNA levels in both the K8 knockdown clones compared to vector control cells (Fig. 1A-C ). This could be further validated by immunofluorescence imaging (Fig. 1D) . K18, the preferential binding partner of K8, showed a significant reduction at its protein level (~50%) as shown by immunoblotting, whereas the mRNA levels of the same were unaffected, indicating that the reduction in K18 was due to decreased protein stability in the absence of its type II binding partner, i.e., K8 (Fig. 1A-C) . Moreover, we observed a significant upregulation of K7 at protein levels, which is a probable binding partner of K18 in the absence of K8 (Fig. 1A) [31, 32] . Nonetheless, immunofluorescence imaging for K18 not only showed reduction in its proteins level but also a loss of normal filament architecture for the residual K18 (Fig. 1D ). This suggests that K7/18 might be forming protofilaments rather than matured-filaments after K8 knockdown. K14 (an important keratin of squamous epithelia) could not be detected at both protein as well as mRNA levels (Fig. 1A,B) . Here, AW13516, an oral SCC-derived cell line, was used as a positive control for K14 expression.
K8 knockdown leads to a reduction in the cell transformation potential of A431 cells both in vitro and in vivo
Reduction in cell motility and invasion
To assess the effect of K8 knockdown on migratory potential of A431 cells, scratch wound healing assay was performed. K8 knockdown cells (K8 -KD1 and K8-KD2) demonstrated a significant reduction (~50-60%) in cell motility compared to vector control cells (P < 0.0001) ( Fig. 2A) . In addition, K8 knockdown cells (K8-KD1 and K8-KD2) showed a significant decrease in their invasive potential, compared to vector control cells (~60-70%) as shown by matrigel invasion assay (P < 0.001 and 0.0005, respectively) (Fig. 2B ).
K8 knockdown clones showed reduction in anchorage independent cell growth and cell proliferation
In order to find out the effect of K8 downregulation on anchorage independent cell growth of A431 cells, soft agar assay was performed on the K8 knockdown (K8-KD1/K8-KD2) and vector control cells. A significant reduction was observed in size (~60-70%; P < 0.0005) and number of colonies formed (~50-60%; P < 0.0005/P < 0.001) by K8 knockdown cells in soft agar colony formation assay, compared with vector control cells (Fig. 2C ). In addition, to evaluate the effect of K8 knockdown on proliferative potential of A431 cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability and clonogenic assays were performed. K8 knockdown clones showed a significant reduction in cell proliferation, compared to vector control cells in MTT cell viability assay (Fig. 2D) . The difference in cell proliferation upon K8 knockdown was further supported by, clonogenic assay. Here we could see a significant reduction in number of colonies (~70-80%) in K8 knockdown clones compared to vector control clone (P < 0.0005 and P < 0.001) (Fig. 2E) . Alongside, there was a visible decrease in colony size in K8 knockdown clones compared to vector control clone. , and K14 levels in pTU6 vector control (VC) and K8 knockdown clones (K8-KD1/K8-KD2). GAPDH was used as internal control. The cDNA from AW13516 cell line was used as a positive control. (C) Bar graph depicting real-time PCR analysis of K8 and K18 relative mRNA levels in pTU6 vector control (VC) and K8 knockdown clones (K8-KD1/K8-KD2) with AESEM for three independent experiments done in duplicates. GAPDH was used as internal control for data normalization; (P value <0.0005). (D) Representative immunofluorescence images for K8 and K18, stained with Alexa flour 488 (Green), whereas the nucleus is counterstained with the DAPI (Blue). Images were taken with Laser confocal microscope (Nikon LSM-meta510; Scale bars = 20 lm).
In vivo tumorigenicity assay
To assess the effect of K8 knockdown on tumorigenic potential of A431 cells, the in vivo tumorigenicity assay was performed as depicted in Material and methods section. Figure 3A shows the representative pictures of mice injected with each of the clones. There was a delayed onset in tumor formation in case of K8 knockdown cells, i.e., 2 weeks post subcutaneous injection, whereas the vector control cells formed tumors within 1 week. The mean volume of the tumors formed by K8 knockdown clones was significantly lower than the average volume of tumors formed by the vector control cells (P < 0.0005/ P < 0.001) suggesting a significant reduction in Fig. 2 . K8 knockdown resulted in reduced cell migration, invasion, soft agar colony formation, and proliferative potential of A431 cells: (A) Scratch wound healing assay of pTU6 vector control (VC) and K8 knockdown clones (K8-KD1/K8-KD2). Phase contrast images (Axiovert 200M Inverted Carl Zeiss microscope; Magnification-1009) of wound closure at 0 h, 3 h, and 6 h are shown (upper panel). Migration rate was calculated by Mac biophotonics IMAGEJ software. The data shown are the average from three independent experiments with the mean and standard deviation (P < 0.0001) as shown in the bar graph (lower panel). (B) Boyden chamber invasion assay of pTU6 vector control (VC) and K8 knockdown clones (K8-KD1/K8-KD2). Membrane filter inserts were coated with matrigel and cells were seeded in the upper chamber. After 12 h of incubation, the cells that invaded through the membrane were stained with DAPI and images were captured using upright microscope Axio Imager.Z1. A representative field for each clone has been shown in the figure (Magnification-2009) (Upper panel). Cell invasion was quantified by counting cells in all the fields using METAMORPH software. The data shown are the average from three independent experiments with the mean and standard deviation (P < 0.001 and 0.0005 for K8-KD1 and K8-KD2, respectively) (Lower panel). (C) Representative phase contrast (Axiovert 200M Inverted Carl Zeiss microscope; Magnification-1009) images of soft agar colonies for pTU6 vector control (VC) or K8 knockdown clones (K8-KD1/K8-KD2) after 14 days (Upper panel). Bar graph shows the total number of colonies formed per plate by the respective clones. Mean and standard deviation of three independent experiments is plotted for size (calculated by Mac Biophotonics IMAGEJ software; P < 0.0005) and number of colonies (P < 0.001 and 0.0005) formed, (Lower panel). (D) The graph corresponds to MTT cell viability assay for pTU6 vector control and K8 knockdown (K8-KD1/K8-KD2) cells. Each point represents the mean and the standard errors of three independent experiments done in triplicate. (E) Representative images of colony-forming assay for pTU6 vector control and K8 knockdown (K8-KD1/K8-KD2) cells after staining with crystal violet (Left panel). Bar graph shows the total number of colonies formed per plate by the respective clones. Mean and standard deviation of three independent experiments is plotted for the number of colonies (P < 0.001 and P < 0.0005) formed (Right panel).
tumorigenic potential of A431 cells after K8 downregulation (Fig. 3B,C) .
Deciphering molecular mechanism associated with K8-mediated regulation of tumorigenic potential of A431 cells
To understand the molecular basis of K8-mediated regulation of tumorigenic potential of A431 cells, TMTbased total quantitative proteomics was performed for VC, K8-KD1, and K8-KD2 clones (Fig. 4A,B ). There was a total of 2952 proteins detected in the TMT-based total quantitative proteomics, out of which, K8-KD1 clone showed 140 proteins to be differentially expressed, whereas K8-KD2 clone showed 122 proteins to be differentially expressed in comparison to vector control cells (Fig. 4C ). In addition, Venn diagram analysis showed 78 common proteins to be significantly altered (up-/downregulated) in both the K8 knockdown clones compared to vector control cells (Fig. 4D,E) . Furthermore, the heat map was plotted for the differentially regulated proteins (with a cutoff of 1.5-fold) common among both the K8-knockdown clones as shown in the Fig. S1 . Next, Ingenuity pathway analysis (IPA) elucidated cellular pathways like cancer, cell motility, cell death and survival, cellular growth and proliferation, cell morphology, apoptosis, etc., to be modulated upon K8 downregulation (Fig. 4F,G) . The associated molecules which demonstrated a substantial level of differential expression included TMS1, Rho-GDI2, MARCKSL1, RANBP1, 14-3-3c, CDK6, EIF6, SHIP1, etc. (Fig. 4H ). For authentication of the MS/ MS data, quantitative spectra were generated for some of these proteins and were considered for further validation and pathway analysis (Fig. S2 ). To our surprise, aside from these important signaling molecules, some of the keratins like K5, K17, and K15 were also found to be significantly downregulated (Fig. S2) . Therefore, we went ahead to decipher the mechanism associated with altered keratin expression.
Keratin 8-associated changes in keratin 5/17 expression K5/17, a major keratin pair of A431 cells, was found to be significantly decreased (~50%) after K8 knockdown as shown in the quantitative proteomics data (Fig. S2) , which could be confirmed by immunoblotting; however, the transcript levels of the same remain unchanged (Fig. 5A,B) . These results suggest that downregulation of K5/17 upon K8 knockdown could be because of alterations in their protein synthesis or turnover rather than transcriptional regulation. The other possibility was the off target effect of shRNA-based gene silencing as majority of keratins harbor sequence homology among themselves. However, our semiquantitative RT-PCR analysis ruled out this possibility. Consistent with our quantitative proteomics and immunoblotting data, immunofluorescence staining of Keratin 5/17 showed considerable downregulation and disrupted filament architecture in K8 knockdown clones compared to vector control cells (Fig. 5C ).
Loss of K8 affects K17 turnover in A431 cells
As the transcript levels of K5/17 were unaffected, we analyzed turnover of the same at protein levels after K8 knockdown. Generally, keratins are very stable proteins and their turnover time is more than 48 h. In spite of this, CHX (50 lgÁmL À1 )-mediated protein synthesis block for 0 to 12 h time points demonstrated the turnover of K17 to be drastically reduced to less than 1 h in K8 knockdown clones compared to vector control cells (Fig. 5D ). Aside from this, K5 was stable till 12 h and its degradation started by 16 h post CHX treatment. Although reduction in K5 turnover was also very significant, it starts later than K17 degradation (Fig. 5E ). This suggests that K5 gets degraded because of the unavailability of its preferential binding partner K17. These results clearly indicate that K8 downregulation affects stability of K17 at protein level, which in turn leads to K5 degradation. Unlike this, K18 levels were consistent in the K8 knockdown clones after CHX treatment, suggesting its turnover to be unaffected (Fig. 5F ).
Keratin 17 undergoes caspase-mediated degradation upon K8 knockdown
Next, to understand the mechanism associated with K17 degradation, we blocked various protein degradation machineries for different time points and assessed stability of K17. For this, the vector control and knockdown cells were treated with specific reagents to block the degradation machinery together with CHX which blocks protein synthesis. For each experiment, untreated (DMSO served as a vehicle control wherever required), only CHX treated, only degradation blocking reagent treated and cells treated with CHX, as well as blocking reagents were used as indicated in Fig. 6A . The pattern of K17 degradation was observed for different time points by immunoblotting for all the four sets in vector control and knockdown cells. Proteasomal degradation is known to regulate keratin turnover [33] . Therefore, MG132 was used to block proteasomal degradation for different time points until 6 h. Immunoblotting followed by proteasomal block did not show any significant alteration in stability of K17 in both the K8 knockdown clones (K8-KD1/K8-KD2) compared to vector control cells (Fig. 6B) . Furthermore, lysosomal degradation was blocked by chloroquine (CQN) treatment for 12 h. The western blot data did not show any significant alteration in K17 stability after lysosomal block (Fig. 6C) . Blocking calpain with E64D for 6 h followed by immunoblotting in similar fashion did not show any changes in K17 protein stability (Fig. 6D) . Together, these results suggest that, alterations in K17 stability were not due to changes in any of these major protein degradation machineries. Another important group of proteases, known to cleave keratins are caspases [16, 34] . Therefore, we blocked caspases with Z-VAD-FMK (a pan caspase inhibitor) for 8 h (Fig. 6E-G) . Interestingly, a significant stabilization of K17 at protein level could be observed after pan caspase inhibition in K8 knockdown clones. Furthermore, to identify specific caspases involved in K17 degradation, we inhibited caspase 8, 9, and the final effector caspase 3 for 12 h and assessed K17 level in K8 knockdown clones compared to vector control cells (Fig. 6H) . Caspase 3 and 8 inhibitors showed a substantial stabilization of K17 levels in K8 knockdown clones, whereas caspase 9 did not show any change (Fig. 6I,J) . These results indicate that K17 undergoes caspase-mediated degradation specifically through caspase 3 and 8 upon loss of K8. 
K8 regulates apoptotic sensitivity of A431 cells
It is known that K17 together with K15 undergoes caspase-mediated degradation during TNF-a-induced apoptosis. Therefore, we checked the apoptotic sensitivity of K8 knockdown clones after 20 h of TNF-a (100 ngÁmL
À1
) and CHX (50 lgÁmL À1 ) treatment. Annexin-V staining was performed to assess the extent of apoptosis. There was a two-to threefold increase in apoptotic cells in K8 knockdown clones compared to vector control cells, which suggests an increased sensitivity of K8 knockdown clones toward apoptotic stimuli (Fig. 6K,L) . This might be a probable reason for K17 degradation after K8 knockdown.
K8 regulates 'cell death and survival' through TMS1-NF-jB pathway TMS1/ACS is known to be a potent regulator of TNFa-mediated apoptosis and is epigenetically silenced during various malignancies [35] [36] [37] . TMS1 was found to be upregulated in our quantitative proteomics data and further validated by western blot analysis (Fig. 7A ). It is a known regulator of NF-jB activity, both positively and negatively during TNF-a-induced apoptosis [38] . Therefore, we evaluated transcriptional activity of NFjB using luciferase reporter assay (Fig. 7B ). The experiment was performed in both TNF-a treated and untreated conditions and the results were normalized with renilla luciferase. The K8 knockdown clones showed 2-to 2.5-fold downregulation in NF-jB transcriptional activity in both the treated as well as untreated conditions compared to vector control cells (Fig. 7C) . NF-jB transcriptional activity is known to be largely dependent on its nuclear localization. Therefore, we performed immunofluorescence analysis for NF-jB after 20 mins of TNF-a treatment. The data showed two-to threefold decrease in NF-jB nuclear translocation in both the K8 knockdown clones (K8-KD1/K8-KD2) compared to vector control cells (Fig. 7D,E) .
IjBa is a well-known upstream regulator of NF-jB activity [39] . Therefore, the turnover of IjBa was analyzed post CHX treatment for 0, 8, 12, and 16 h time points. The western blot analysis demonstrated a significant difference in the stability of IjBa in K8 knockdown clones compared to vector control cells ( Fig. 7F) . In K8 knockdown cells, IjBa was stable for more than 8 h, whereas in vector control cells, it gets degraded much earlier (within 8 h). Additionally, even after 20 min of TNF-a treatment, the IjBa was more stable in K8 knockdown clones compared to vector control cells (Fig. 7G ). This was accompanied by its The data shown are the average from three independent experiments with the mean and standard deviation (P < 0.001 for K8-KD1 and P < 0.0005 K8-KD2).
decreased phosphorylation at S32/S36 residues post 5 min TNF-a treatment (Fig. 7H) . Furthermore, the stability of IjBa is largely dependent on its phosphorylation by IjBa kinase complex (IKK) which is required for its degradation. IKK complex is activated itself after IKKb Y188 phosphorylation [40] . K8 knockdown clones showed significant reduction in phosphorylation of IKKb at Y188 compared to vector control cells as shown by the western blot data. Additionally, the total protein levels of PKC delta, an upstream regulator of IKK phosphorylation during NFkB mediated apoptosis [41, 42] , were also significantly reduced in K8 knockdown clones compared to vector control cells (Fig. 7I) . Aside from this, other associated modulators of same pathway like AKT/ pAKT, ERK/pERK, did not show any changes; however, the stress-activated kinase JNK showed a significantly increased phosphorylation levels after K8 knockdown (Fig. 7J,K) . This is an important event after diminished NF-jB activity during apoptosis, which further strengthened our hypothesis (Fig. 7L) .
Moreover, it has also been shown that NF-jB activity together with 14-3-3c affects centrosome amplification and thereby tumor progression. In association with this, overexpression of a RAN-binding protein (RanBP1) is shown to induce multipolar spindles by affecting mitotic centrosome cohesion and microtubule stability. This has further been shown to increase the sensitivity of cancer cells toward microtubule targeting drugs like taxol in a caspase 3-dependent manner. Our quantitative proteomics data showed a significant downregulation of RANBP1 and upregulation of 14-3-3c in K8 knockdown clones compared to vector control cells which could be validated by western blotting (Fig. 8A) . As a proof of principle, we further assessed the effect of K8 downregulation on centrosome number in A431 cells. For this we first synchronized these cells in M phase by adding 200 ngÁmL À1 of nocodazole in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS for 20-24 h. The cells were then stained with antibodies to pericentrin and a-tubulin (Fig. 8B ). We observed a significant reduction in centrosome number per cell in K8 knockdown clones compared to vector control cells (Fig. 8C ). This suggests that K8 might be affecting centrosome number through RANBP1 and in turn apoptotic sensitivity of these cells. Altogether, these data suggest the loss of K8 altered 'Cell death and survival' of A431 cells by regulating an array of signaling molecules (Fig. 8D ).
K8 downregulation affects cell migrationassociated signaling pathway in A431 cells
Consistent with phenotypic assays differential expression of molecules associated with cell motility were found to be altered upon K8 downregulation, as shown in IPA analysis. One of them is MARCKSL1, an actin organization-associated protein [43] , was significantly upregulated in both the K8 knockdown clones compared to vector control cells in the differential quantitative proteomics data. This was further confirmed by western blotting. The downstream effector of MARCKSL1, i.e., paxillin [44, 45] , showed an increased phosphorylation at Y118 residue, which is known to activate it. Increased phosphorylation of paxillin is responsible for focal contact formation in association with FAK. Furthermore, FAK phosphorylation/dephosphorylation is responsible for mature focal adhesion formation and retraction of the same during cell migration [46] . Downregulation of K8 led to a decreased phosphorylation of FAK at S397, which is necessary for its activity (Fig. 9A ). This suggests a possible deregulation of focal contact formation, maturation, and retraction at the cell edges. This could be further confirmed by paxillin immunostaining in both K8 knockdown and vector control cells (Fig. 9B ). This showed an increased paxillin puncta at the membrane of both K8 knockdown clones (K8-KD1/K8-KD2), whereas vector control cells showed paxillin organization as lamellipodia like membrane extensions. Aside from this, previous studies have shown that paxillin phosphorylation in the absence of FAK leads to the formation of shorter actin filaments. We also observed similar alterations in actin filament architecture, when stained with phalloidin-FITC, which binds exclusively to filamentous actin. The K8 knockdown clones showed shorter actin fibers compared to vector control cells, with mature elongated cortical actin fibers along the arch (Fig. 9C) .
Loss of K8 regulates lamellipodial organization through altered RAC activity and thereby cell migration FAK phosphorylation is also known to affect Rho-GTPase activity which regulates actin-associated membrane protrusions, e.g., fillopodia (CDC42), lamellipodia (RAC1), and stress fibers (Rho) at the migratory front [47] . To identify the probable RhoGTPase regulating K8-mediated migratory phenotype, actin staining at migratory edges for K8 knockdown and vector control cells was carried out. This demonstrated a clear mature lamellipodial organization in the migratory edges of vector control cells, whereas knockdown cells showed immature lamellipodial organization (Fig. 9D ). In addition, the lamellipodial organization post epidermal growth factor (EGF) treatment (20 ngÁmL À1 for 5 min) was also found to be negatively affected after K8 knockdown compared to vector control cells (Fig. 9E ). In accordance with this observation, active RAC (RAC-GTP) levels were also found to be significantly decreased after 5 min of EGF treatment in K8 knockdown cells compared to vector control cells as assessed by RAC-GTP pulldown assay (Fig. 9F ). This suggests that RAC activity modulates lamellipodial organization and affects cell migration in K8-dependent manner. Another important protein Rho-GDI, which is an upstream regulator of RAC signaling pathway, was upregulated after K8 knockdown, validating our quantitative proteomics data. In addition, cofilin, an important downstream modulator of RAC activity, which bears actin severing properties and thereby affects actin organization, was further analyzed in K8 knockdown and vector control cells. We did not see any change in total cofilin levels, while its phosphorylation at S3 was found to be increased after K8 knockdown, indicating its inactivation and thereby modulation of RAC mediated actin organization. We have also observed a significant upregulation in 14-3-3c levels after K8 knockdown (Fig. 9G ). Similar observations have been made by Kensaku Mizuno group, where they have shown RAC-mediated regulation of Cofilin-1 phosphorylation by inhibition of binding of Slingshot phosphatases to 14-3-3c. Together, these results indicate that K8 regulates cell migration by modulation of MARCKSL1-FAK-RAC signaling axis in A431 cells (Fig. 9H) .
Rescue of phenotypic and molecular changes observed in K8 knockdown clones by reexpression of shRNA resistant K8-WT-GFP
To determine that the effects associated with K8 knockdown were not due to off target effects of the shRNA, a rescue experiment was performed by reexpressing the shRNA-resistant K8-WT-GFP and only GFP (GFP-VC) in K8 knockdown background (Fig. 10A) . At phenotypic level, the in vivo tumorigenicity assay showed an early onset and large tumor volume in case of mice injected with stable clones expressing K8-WT-GFP as compared to GFP-VC cells (P < 0.0005) (Fig. 10B-D) . This suggested a reversal in the tumorigenic potential of A431 cells upon reexpression of K8-WT-GFP in K8 deficient background. Upon K8-WT-GFP re-expression, the K5 and K17 levels were substantially stabilized as shown in the western blot (Fig. 10E ) and immunofluorescence data (Fig. 10F) . The K17 levels were stable up to 12 h in K8-WT-GFP clone compared to K8 knockdown cells (K8-KD1). Aside from this, there was a reversal in the protein levels of molecules associated with apoptotic and migratory pathways such as TMS1, JNK/ pJNK, MARCKSL1, Paxillin/pPaxillin, and Cofilin/ pCofilin (Fig. 10G) . Together, these observations confirmed the role of K8 in neoplastic progression of skin SCC-derived A431 cells through the regulation of these migratory and apoptosis associated proteins.
Validation of quantitative proteomics and in vitro data by immunohistochemical analysis of differentially expressed proteins, proliferation marker (Ki67) and TUNEL assay on mice tumor samples
To validate our findings in vivo, a subset of the identified candidate proteins was selected for immunohistochemical analysis on mice tumor tissue sections, based on their possible functions in 'Cell death and survival' or 'Cellular movement pathway' in response to K8 downregulation. IHC analysis was performed on tumor tissue sections derived from pTU6 vector control, both the knockdown clones, GFP-VC and K8-WT clone (however for better representation we have only shown the data from one of the K8 knockdown clone, i.e., K8-KD1). IHC analysis of tumor tissue sections with K8 specific antibody, confirmed a persistent reduction of K8 levels in tumors derived from K8 knockdown clones compared to vector control. Similarly, upregulation of K8 could be confirmed in tumors derived from K8-WT clone compared with GFP-VC. The IHC analysis of differentially expressed proteins which correlated with apoptosis, proliferation, or migration (TMS1, RANBP1, K17, 14-3-3c, MARCKSL1, and Rho-GDI) showed the expected expression pattern in the respective tumor tissue sections, validating our in vitro data. Furthermore, IHC analysis of tumor tissue sections derived from K8-WT clones demonstrated reversal of the same (Fig. 11A) . Next, to assess if the delayed onset and decreased tumor volume in the xenograft model is because of increased apoptotic sensitivity or altered proliferation upon K8 downregulation, we performed Ki67 staining and TUNEL assay, respectively. In accordance with our in vitro data, we could not detect any apoptotic cells in TUNEL assay, as there was no induction given to the cells while injecting them or afterwards (Fig. S3) . Nevertheless, a marked reduction in Ki67-positive cells was observed in tumor tissue sections derived from K8 knockdown clones compared to vector control (P value <0.001). Rescue of the same in K8-WT clones compared to GFP-VC with a P value of <0.0005 (Fig. 11B) . Altogether, these results not only confirmed our quantitative proteomics as well as in vitro data in the xenograft model but also suggested decreased proliferation to be a possible reason for difference in tumorigenic potential of A431 cells in vivo upon K8 downregulation.
Discussion
The tissue-specific and differentiation state-dependent expression pattern is one of the major characteristic of all the keratin intermediate filaments [23, 48] . However, Keratin 8/18, a preferential keratin pair of simple epithelial tissue is reported to be aberrantly expressed in different squamous cell carcinomas. Its aberrant expression has been correlated with increased invasiveness and poor prognosis of these tissues [22, 23, 49] . Although, K8/18 pair is known to be aberrantly expressed in skin cancers [20] , till now, there are no reports about its role in the neoplastic progression of skin SCCs and the mechanisms associated with it. Here we have shown that loss of K8 leads to a significant reduction in tumorigenic potential of skin SCC-derived A431 cells. In agreement with this, our quantitative proteomics data followed by IPA analysis showed most of differentially expressed proteins to be involved in biological pathways associated with cancer. Furthermore, in accordance with available literature, we could identify molecular mechanism involved in 'Cell death and survival' (TMS1-NF-jB and K17 degradation) as well as 'Cellular movement' (MARCKSL1-Paxillin1 and Rac activity) pathways upon K8 downregulation. Consistent with our phenotypic data, a previous report by Casanova et al. demonstrated that skin carcinogenesis on transgenic mice expressing K8 alters the epidermal cell differentiation, favors the neoplastic transformation of cells, and is responsible for the invasive behavior of transformed epidermal cells, leading to faster conversion of benign tumors to malignant ones [30, 50] . In addition, a previous report from our laboratory has shown that K8 downregulation in an oral SCC-derived AW13516 cells resulted in decreased tumorigenic potential of these cells [26] . Together these reports suggest a potent role of K8 in neoplastic progression of SCC irrespective of their site of origin.
Furthermore, in concordance with earlier reports, we could see a substantial reduction in K18 protein levels, most likely because of the destabilization in the absence of its preferential type II binding partner, i.e., K8 [26, 51] . Surprisingly, there was also a significant decrease in the levels of K5/17 (a predominant keratin pair of A431 cells [52] ) and K15 upon K8 knockdown as shown in the differential quantitative proteomics data. The protein-level validation together with protein turnover analysis of K5/17 indicated that K8 downregulation affects the stability of K17. In addition, we found that K17 undergoes caspase-mediated degradation upon K8 knockdown. Consistent with this observation, an earlier report demonstrated caspasemediated degradation of K17 as well as K15, during TNF-a-induced apoptosis [53] . These results suggested that depletion of K17 upon K8 downregulation is possibly due to increased sensitivity of A431 cells toward apoptotic stimuli. This was further confirmed by Annexin-V staining post TNF-a/CHX treatment. In addition, we observed a subsequent reduction in K5 levels after the depletion of K17 upon K8 knockdown. This is probably because of unavailability of K17 to hetero-dimerize and stabilize K5 in turn leading to its degradation. The same could be rescued upon K8 reexpression, further strengthening our hypothesis. In case of simple epithelia, K8/18 is a major keratin pair and one of its important functions is to provide resistance toward stress and apoptosis [54, 55] . Similarly, Keratin 8/18-dependent resistance to TNF-a-mediated apoptosis has been shown earlier by Oshima et al. [56] . It is also suggested that during apoptosis or stress conditions, keratins undergo caspase-mediated cleavage and reorganization which may initiate the orderly processing of the filament proteins during apoptosis in epithelial cells [34, 57] . K5/17 degradation after K8 knockdown might be performing the same function as it is the major keratin pair of A431 cells. In addition to this, Annexin-V staining suggested that K8 might be offering a survival benefit to A431 cells by providing resistance toward apoptosis. Therefore, its downregulation leads to increased sensitivity of A431 cells which might be resulting in the degradation of K17, in turn affecting 'Cell death and survival' pathway of these cells. This also explains the probable reason behind the slow growing capacity of K8 knockdown clones as suggested by the clonogenic and MTT cell viability assays. Aside from this, there is an emerging role of K17 in proliferation as well as apoptosis. For instance, in hair follicles, K17 is crucial for mechanical support and promotes the anagen phase of the hair cycle by antagonizing TNF-a-induced apoptosis. K17 expression is also shown to be induced in regenerative epithelia and different types of cancers [1] . Furthermore, in various malignancies, induction of K17 expression has been observed, which could be associated with poor prognosis [58] [59] [60] . Increased K17 expression is also considered as a marker of keratinocyte proliferation [61] . A recent report suggested an important role of K17 in regulation of signaling pathways such as Akt/mTOR in OSCC and Hedgehog (Hh) in basal cell carcinomas (BCC) [60, 62] . Altogether, these reports support our in vitro data and suggest a possible role of K17-mediated regulation of 'Cell death and survival' to be involved in decreased tumorigenic potential of A431 cells in the absence of K8.
In agreement with this, as shown in our differential proteomics data, there was a two-to sixfold upregulation of TMS1, a card domain containing apoptosisassociated protein. TMS1 is shown to be epigenetically silenced in many cancers and is associated with their tumorigenic potential [35] [36] [37] . These observations support our phenotypic analysis. Furthermore, TMS1 has been shown to regulate apoptosis through NF-jB signaling by modulating IKK phosphorylation and in turn IjBa stability [38] . We could observe the same pathway to be altered in A431 cells upon loss of K8. NF-jB is a dual regulator of apoptosis, although in majority of the cases it regulates the transcription of antiapoptotic genes [63] [64] [65] . A significant reduction in PKCd and activation of JNK pathway supports reduction in its antiapoptotic function upon loss of K8. Various reports have shown contrasting roles of PKCd in Cell Survival together with cell death and its involvement in activation of IjB kinase [41, 42] . This further supported our data. Moreover, it has been reported that the absence of NF-jB mediates inhibition of c-Jun N-terminal kinase activation leading to TNF-a-induced apoptosis [66] . In addition, Ranbinding protein 1 (RanBP1), a major effector of Ran, is reported to be overexpressed in many cancer types. It has been observed that, RanBP1 is involved in regulating the function of the mitotic apparatus. Overexpression of RanBP1 induces multipolar spindles generated through loss of cohesion in mitotic centrosomes. Together with this, its inactivation gives rise to hyper-stable MTs resulting in apoptosis induction during mitosis. Furthermore, it has also been shown that RanBP1 downregulation resulted in an increased apoptotic response to taxol in a caspase-3-dependent manner in various transformed cell lines [67] . When we stained K8 knockdown cells for centrosome as well as microtubule, we could see a reduction in centrosome number per cell together with RANBP1 downregulation as observed in our differential proteomics data and western blot. This might be an important link between K8 downregulation and increased sensitivity of A431 cells toward apoptotic stimuli. Aside from this, upregulation in 14-3-3c levels and decreased NF-jB activity, further supports this hypothesis [68, 69] .
In congruence with our in vitro data, we further performed immunohistochemistry for Ki67 as well as TUNEL assay in the tumor tissue sections derived from pTU6 vector control, K8 knockdown, GFP-VC, and K8 wild-type clones. A reduction in the number of Ki67-positive cells in K8 knockdown clone compared to vector control cells was observed. K8-WT expressing cells also showed rescue of the same. In agreement with our in vitro data as expected, there were no TUNELpositive cells detected in the tumor tissue sections derived from respective clones, probably because we have not given any apoptotic induction to the cells before or after injecting them into the mice. These observations indicate that the difference in tumor volume in the xenograft model is because of the altered proliferative potential of these cells. Nonetheless, it does not completely rule out the possibility of altered apoptotic pathways upon K8 depletion as we could validate the levels of apoptosis associated proteins (TMS1, K17, RANBP1 & 14-3-3c) in these tumors. Altogether, our data in association with the available literature suggest that K8 might be providing survival benefits to A431 cells by differentially regulating many new effectors associated with apoptotic signaling pathway and thereby 'Cell death and survival' (Fig. 8D) .
Aside from apoptosis and proliferation, another important factor involved in metastatic potential of a cancer cell is their migratory and invasive ability. Our phenotypic assays showed a significant reduction in migratory and invasive potential of A431 cells upon K8 downregulation. Also, our IPA analysis revealed 'Actin organization' and 'Cellular movement' pathways to be affected upon K8 downregulation. It is well-documented that cell migration is a highly integrated multistep process that is initiated by the protrusions of the cell membrane. Protruding structures formed by migrating and invading cells could be either filopodia, lamellipodia, or invadopodia/podosomes, on the basis of their morphological, structural, and functional characters [70] . Formation of these structures is driven by spatiotemporally regulated actin polymerization at the leading edges. Our differential proteomics data followed by in vitro as well as in vivo analysis showed MARCKSL1 upregulation upon K8 loss which is one of the important regulator of 'Cellular movement'. MARCKSL1 is known to regulate actin cytoskeleton homeostasis together with filopodium and lamellipodium formation during cell migration. The key downstream target of MARCKSL1, paxillin [43, 71, 72] , is shown to localize at discrete structures in the cells called focal adhesions which are sites of close cellular contact with the underlying extracellular matrix. The Y118 phosphorylation of paxillin is important for its activity at focal contacts during fibrillogenesis and cell migration [44, 45] . Paxillin phosphorylation together with FAK initiates focal contact formation; however, further maturation and disassembly of focal contacts for proper cell migration requires FAK phosphorylation [46] . In the present study, loss of K8 resulted in an increased paxillin phosphorylation at Y118 along with decreased FAK phosphorylation at S397. According to a previous report, paxillin in the absence of FAK phosphorylation can initiate the focal contact formation, while maturation and fibrillogenesis of the same is inhibited, leading to decreased migratory potential. This might be the possible reason behind decreased motility of K8 knockdown cells. Additionally, we could observe more of paxillin staining at the cell periphery of the K8 knockdown cells compared to vector control, further supporting our hypothesis. Furthermore, shorter actin filaments were observed in case of K8 knockdown clones which corroborated with an earlier observation where more paxillin phosphorylation resulted in shorter actin bundles [72] . FAK also plays an important role in regulating Rho-GTPases activity and in turn cell migration [73, 74] . Our actin staining showed mature lamellipodial organization in vector control cells together with more RAC activity. This suggests that decreased FAK dephosphorylation together with less RAC activity might be responsible for less migratory phenotype of A431 cells, after K8 knockdown. This was also supported by increased expression of Rho-GDI, a key regulator of Rho-GTPases, in response to K8 depletion as shown in our quantitative proteomics, in vitro and in vivo data. Downstream effector of Rac activity and actin dynamics, i.e., cofilin, is an actin severing protein which gets inactivated upon S3 phosphorylation [75] . We could observe a significant increase in cofilin inactivating phosphorylation upon impaired RAC activity. Previous reports suggest that active RAC leads to downstream activation of slingshot phosphatases by releasing them from 14-3-3c. In the absence of RAC activity, slingshot phosphatases are inactivated, resulting in more and more accumulation of phosphorylated and inactivated cofilin [76] [77] [78] . Accordingly, we also observed a substantial increase in 14-3-3c level upon loss of K8. Previously, it has been shown that if there are shorter actin filament bundles in a cell, it causes the inactivation of cofilin by increased S3 phosphorylation to seize its actin severing activity as a feedback loop [79] . Similar observations have been made by us, which in turn substantiated the role of increased cofilin phosphorylation leading to impaired cell migration upon K8 downregulation. Finally, re-expression of K8-WT-GFP in the K8 knockdown background resulted in the rescue of the molecular changes associated with both apoptosis (TMS1, RanBP1, K17 degradation) as well as migration (MRCKSL1, Paxillin1/ pPaxillin1, Cofillin/pCofillin) as shown by western blot analysis. Few of these proteins were validated in vivo in tumor tissue sections derived from K8-WT clones further strengthening the involvement of K8 in regulation of these pathways. Besides we did not observe any changes in AKT/pAKT, or ERK/pERK levels suggesting that these pathways might not be involved in K8 mediated regulation of skin SCC (Fig. 9H) . In summary, loss of K8 in A431 cells led to decreased tumorigenicity of these cells as shown by our in vitro as well as in vivo data. Quantitative proteomics revealed significant links between K8 and the associated phenotypic changes, including TMS1, RANBP1, 14-3-3c, MARCKSL1, and Rho-GDI. Further protein level validation followed by functional analysis demonstrated altered apoptotic sensitivity and migratory potential of these cells, probably by modulating TMS1-NF-jBmediated K17 degradation and MARCKSL1-Paxillin1-Rac activity axis, respectively. On the whole, this study provides new connecting links between K8 and different cancer related signaling pathways and thereby emphasizes its role in neoplastic progression of skin SCC. Our study also has given many new leads related to the possible mechanisms underlying these phenomena. Further dissecting these signaling cascades in relation to K8 will be important in developing new strategies for the treatment of cancer. If validated on human skin SCC tissue samples, K8/18 and its downstream effectors can act as promising prognostic markers or drug targets.
Materials and methods
Plasmids, cloning, and virus production pTU6-puro vector backbone and pTU6-puro-Sh RNA-K8.2 were used to generate vector control and K8 knockdown clones, respectively, in A431 cells as described earlier [26] . For rescue experiments, shRNA-resistant pLNCX2 3XFlag-K8-WT-GFP construct generated earlier was used [80] . To generate pLNCX2 3XFlag-GFP vector backbone, K8 was excised out from the pLNCX2 3XFlag-K8-WT-GFP by HindIII enzyme and the remaining backbone was religated. To generate high titer retroviral particles, the shRNA-resistant K8 wild-type (pLNCX2 3XFlag-K8-WT-GFP) or pLNCX2 3XFlag-GFP vector control together with the packaging plasmids (pCL-Eco and pMD2.G) were cotransfected in HEK293-FT cells (at 70-80% confluency) by X-tremeGENE TM HP DNA Transfection Reagent (Roche, Basel, Switzerland) according to the manufacturer' protocol. After 48 h, supernatant was collected and then ultracentrifugation was carried out at 25 000 g for 90 min each. The pellet was further resuspended in 100 lL of incomplete DMEM and used to generate shRNA-resistant K8-WT-GFP stable clones and pLNCX2 3XFlag-GFP vector control in K8 knockdown background.
Cell lines, reagents used, and generation of stable clones
The skin epidermoid carcinoma derived cell line A431 and HEK293-FT cells (ATCC) were cultured in DMEM (Gibco, Waltham, MA, USA), supplemented with 10% fetal bovine serum (FBS; Gibco) and antibiotics, at 37°C and under a 5% CO 2 atmosphere. The list of reagents was given in Table S1 . To generate pTU6 puro vector control and K8 knockdown clones, A431 cells were transfected with pTU6 puro empty vector and pTU6 shRNA K8.2 with the help of X-tremeGENE TM HP DNA transfection reagent (Roche) according to the manufacturer's protocol, respectively. The stable clones with significant K8 downregulation were then selected and maintained in 500 ngÁmL À1 of puromycin and were validated with different biochemical techniques. Two of the K8 knockdown clones thus generated (K8KD1/K8KD2) were further transduced with the viral particles for shRNA-resistant K8 wild-type (pLNCX2-3XFlag K8-WT-GFP) and GFP vector backbone (pLNCX2-3XFlag-GFP as GFP-VC), respectively. Stable clones were then selected and maintained in 500 ngÁmL À1 of puromycin and 600 lgÁmL À1 of G418 sulfate.
Western blot and immunofluorescence analysis
Western blotting and immunofluorescence analysis were performed as described in previous report [26, 80, 81] . List of antibodies used is given in In vitro scratch wound healing assay
To assess the migratory potential of A431 cells scratch wound healing assay was performed as described previously [26] . Cells were grown on six-well plates to 95% confluency then treated with plain DMEM containing 20 lgÁmL 
Boyden chamber cell invasion assay
The invasiveness of the cells was determined by the Boyden chamber invasion assay as shown earlier [26] . In brief, 40 lL Matrigel (1 mgÁmL
À1
) with 140 lL plain DMEM was applied to 8 lm-pore-size polycarbonate membrane filters and the bottom chamber was filled with 0.6 mL of complete DMEM. About 2 9 10 4 cells were seeded in the chamber in serum-free medium, and then incubated for 16 h at 37°C. At the 15 h, the cells on the upper surface were carefully removed with a cotton swab. The membranes containing invaded cells were fixed with 4% PFA and stained with DAPI. The invasiveness was quantified by counting 25 random fields under an upright microscope Axio Imager.Z1. Results obtained from three independent experiments each in triplicate were represented as mean values using AESEM obtained from software GRAPHPAD PRISM 5 (San Diego, CA, USA).
MTT cell viability assay
The MTT cell viability assay was performed as described earlier [26] . For this, 2000 cells/100 lL were seeded per well, in a 96-well microtitre plate. Proliferation was studied every 24 h up to a period of 4 days. At the desired time points, 100 lL of the medium was replenished from the designated wells and 20 lL MTT solution (5 mgÁmL
À1
MTT in 1X PBS) was added to each well. Plate was incubated at 37°C in a CO 2 incubator for 4 h, then 100 lL of acidified SDS (10% SDS in 0.01N HCl) was added to each well and incubated overnight at 37°C. Next day, the absorbance was measured on an ELISA plate reader at 540 nm against a reference wavelength of 690 nm. Growth curve was plotted from three independent experiments.
Colony-forming assay
Colony-forming assay was performed as described earlier [26] . In brief, 200 cells were plated in 60 mm tissue culture plates in triplicates. Cells were grown in complete medium for 14 days, with medium changes every 2-3 days. Cells were first fixed with methanol for 5 min at RT and then washed twice with 1X PBS. They were later stained with crystal violet solution (0.5% crystal violet in 20% methanol) for 5 min at RT. After washes with distilled water, the images of stained cells were captured using high-resolution Nikon camera. The colonies were counted manually. The assay was carried out in triplicates and results were analyzed using GRAPHPAD PRISM 5 software.
Soft agar colony-forming assay
To assess anchorage independent growth of A431 cells, soft agar assay was performed as described earlier [25, 26] . In brief, as a first step, 1 mL of equal volumes of 2X complete DMEM and 2% low melting agarose was layered to prepare basal layer in the 35 mm dish. About 1000 cells in complete medium containing 0.4% low melting agarose were seeded over the basal layer. Plates were fed complete medium on every alternate day and incubated at 37°C in a 5% CO 2 incubator for 15 days. Images were acquired by Axiovert 200 M Inverted Carl Zeiss microscope. Opaque and dense colonies were observed and counted microscopically on day 15. The assay was carried out in triplicates results were analyzed using GRAPHPAD PRISM 5 software.
In vivo tumorigenicity assay
The tumorigenic potential of K8 knockdown/vector control was determined by subcutaneous injection in NOD-SCID mice as described earlier [26] . [82] . During the course of this study, no animal injury/illness or mortality was observed. To set the humane endpoint, the institute's protocol (displayed on the institute's intranet) is being followed by every investigator before the sanction by the IAEC. After each experiment, mice were euthanized by CO 2 , introduced from the cylinder supply valve into a chamber at an optimal flow rate of 20% of the chamber volume for 2-3 min. After verifying the cessation of respiration and heart beats, cervical dislocation was performed by skilled personnel to confirm the death [83] .
Differential quantitative proteomics (cell lysis, protein digestion, and TMT labeling)
The differential quantitative proteomics was performed as described previously [80] . For total proteomics, cell lysates were prepared from A431 parental cell line, pTU6 vector control and K8 knockdown (K8KD1/K8KD2) cells in TEABC lysis buffer (2% SDS, 5 mM sodium fluoride, 1 mM glycerol 2-phosphate, 1 mM sodium orthovanadate in 50 mM Triethyl ammonium bicarbonate). The cell lysates were sonicated and centrifuged at 16 000 g for 10 min. The protein concentration was estimated using bicinchoninic acid assay (Pierce, Waltham, MA, USA). Eight milligram of protein from each cell type was reduced (using DTT at a final concentration of 5 mM at 60°C for 20 min) and alkylated using 10 mM iodoacetamide for 10 min at room temperature in the dark. We employed filtered sample preparation (FASP) protocol as described earlier [84] 
Basic reversed-phase liquid chromatography
Pooled labeled peptides were subjected to bRPLC fractionation generating 96 fractions, as described earlier [85] . The fractions were concatenated into 12 fractions.
LC-MS/MS analysis
The total peptides were analyzed on Orbitrap Fusion TM Tribrid TM Mass Spectrometer (Thermo Electron, Bremen, Germany) interfaced with Easy-nLC 1000 liquid chromatography system (Thermo Scientific, Odense, Denmark). The peptide digests were reconstituted in 0.1% formic acid and loaded onto trap column (75 lm 9 2 cm) packed in-house with Magic C18 AQ (Michrom Bioresources, Inc., Auburn, CA, USA). Peptides were resolved on an analytical column (75 lm 9 20 cm) at a flow rate of 350 nLÁmin À1 using a linear gradient of 10-35% solvent B (0.1% formic acid in 95% acetonitrile) over 80 min. Data-dependent acquisition with full scans in 350-1700 m/z range was carried out using an Orbitrap mass analyzer at a mass resolution of 120 000 at 400 m/z. Fifteen most intense precursor ions from a survey scan were selected for MS/MS which were fragmented using HCD fragmentation with 32% normalized collision energy and detected at a mass resolution of 30 000 at 400 m/z. Dynamic exclusion was set for 30 sec with a 10 ppm mass window. Internal calibration was carried out using lock mass option (m/z 445.1200025) from ambient air.
Mass Spectrometry data analysis
The mass spectrometry-derived data were searched against 'Human Ref Seq protein database' (Version 65, containing 36211 protein entries with common contaminants added) using 'SEQUEST' and 'Mascot' search algorithms through 'Proteome Discoverer' platform (version 1.4.1.14, Thermo Scientific) as described in earlier reports [84, 85] . The search parameters for both algorithms included: carbamidomethylation of cysteine and TMT 10-plex (C229.163) modification at N terminus of peptide and lysine as fixed modifications. MS/MS spectra were searched with a precursor mass tolerance of 10 ppm and fragment mass tolerance of 0.05 Da. Trypsin was specified as protease and a maximum of two missed cleavages were allowed. The data were searched against decoy database and the false discovery rate was set to 1% at the PSM level. Peptide with ratio ≥1.5-fold cutoff was considered for further analysis. The mass spectrometry proteomics data have been deposited to the 'ProteomeXchange Consortium' (http://proteomecentra l.proteomexchange.org) via the PRIDE partner repository [86] with the dataset identifier PXD007206.
Bioinformatics analysis
The mass spectrometry-derived data were searched against 'HPRD' (Version 65, containing 36211 protein entries with common contaminants added) using 'SEQUEST' and 'Mascot' search algorithms through 'Proteome Discoverer' platform (version 1.4.1.14, Thermo Scientific) as described in earlier reports [84, 85] . Proteins with a fold change of ≥1.5 (up/downregulated) were considered for further bioinformatics analysis. To determine the orthogonal or overlapping protein profile among both the knockdown clones, 'Venny2.1 tool' was used. All quantified peptides were analyzed using 'Ingenuity Pathway Analysis' (IPA, Ingenuity systems, Qiagen, used in collaboration with IOB, Bangalore) by core analysis. The overrepresented 'Biological processes', 'Molecular functions,' and 'Canonical pathways' were generated based on information contained in the Ingenuity Pathways Knowledge Base. The significance of the association between the dataset and the canonical pathway was measured in two ways: (a) A ratio of the number of molecules from the dataset that map to the pathway divided by the total number of molecules that map to the canonical pathway is displayed.
(b) Fisher's exact test was used to calculate a P value determining the probability that the association between the genes in the dataset and the 'Canonical pathways' is explained by chance alone. Xcalibur version-3.0 was used to determine the quantitative spectra for selected peptides.
Luciferase Reporter assay pTU6 vector control and K8 knockdown cells were cotransfected with ConA Luc control or 3x KB ConA Luc, pBIND-Renilla-Luc and other relevant vectors by calcium phosphate method. After 36 h post-transfection, cells were lysed and 10 lg lysate was used for the assay. Luciferase assay was performed in a 96-well white plate using Dual Luciferase Assay System (Promega) as per the manufacturer's protocol. Renilla luciferase was used for transfection normalization.
Rac activity assay
Rac activity assay was performed as per manufacture's protocol (RhoA/Rac1/Cdc42 Activation Assay Combo Biochem Kit (bead pull-down format) (Cat. # BK030) Cytoskeleton, Inc. In brief, cells were treated with EGF (20 ngÁmL À1 ) for 5 min and then lysed using the lysis buffer. PAK-PBD beads were used to pull down active RAC from the whole cell lysate. The pull-down fraction was then subjected to western blot analysis. Total RAC was used as a loading control.
Immunohistochemistry and TUNEL assay
Immunohistochemistry was performed on the tumor tissue sections derived from mice injected with pTU6 vector control, K8 knockdown (K8-KD1/KD2), GFP-VC, and K8-WT clones, as described previously [81] . Briefly, tissue samples were fixed in 10% formalin buffer and 5-lm sections were cut from paraffin embedded blocks. Sections were stained with hematoxylin and eosin (H&E) for histological diagnosis. Immunohistochemical staining was performed using Elite ABC Kit (Vector laboratories, Burlingame, CA, USA). The primary antibodies against K8, TMS1, RANBP1, K17, MARCKSL1, Rho-GDI, 14-3-3c, and Ki67 were used and dilutions are mentioned in Table S2 . To determine apoptotic tumor cells, terminal deoxynucleotidyl transferase-deoxyuridine triphosphate nick end labeling (TUNEL) assay was performed on the tumor tissue sections derived from mice injected with pTU6 vector control, K8 knockdown (K8-KD1/KD2), GFP-VC, and K8-WT clones, respectively. The slides were heated at 60°C followed by washing in xylene and rehydration through a graded series of ethanol. The tissue sections were then subjected to TUNEL staining as per the manufacturer's protocol (In situ Apoptosis Detection Kit, MK500, TAKARA, Mountain View, CA, USA). To prepare positive control, one of the tumor tissue sections was treated with 10UÁmL
À1
of DNAase-I for 10 min before adding the TDT mix. The images were captured using upright microscope Axio Imager.Z1 (Magnification-2009).
Statistical analysis
Two groups of data were statistically analyzed by t-test using GRAPHPAD PRISM5 Software. A P value less than 0.05 was considered statistically significant.
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